Albemarle supplies Dr. Reddy’s
This article was originally published in The Tan Sheet
Executive Summary
Albemarle Corp. signs on India-based Dr. Reddy's Laboratories as a non-exclusive distributor of its bulk ibuprofen active pharmaceutical ingredient and to sell and distribute the product within its global client base. Under the terms of the already-in-effect agreement, Baton Rouge, La.-based Albemarle will supply a "substantial quantity" of ibuprofen API for Dr. Reddy's generic ibuprofen tablets, Albemarle says...